Free Trial

HC Wainwright Estimates Transcat's Q1 Earnings (NASDAQ:TRNS)

Transcat logo with Computer and Technology background

Transcat, Inc. (NASDAQ:TRNS - Free Report) - Research analysts at HC Wainwright lowered their Q1 2026 earnings per share estimates for Transcat in a note issued to investors on Wednesday, June 25th. HC Wainwright analyst S. Buck now forecasts that the scientific and technical instruments company will post earnings of $0.37 per share for the quarter, down from their previous estimate of $0.41. HC Wainwright currently has a "Buy" rating and a $116.00 target price on the stock. The consensus estimate for Transcat's current full-year earnings is $2.30 per share. HC Wainwright also issued estimates for Transcat's Q4 2026 earnings at $0.69 EPS.

Separately, Wall Street Zen raised shares of Transcat from a "sell" rating to a "hold" rating in a report on Wednesday, May 28th. Three analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $114.00.

Read Our Latest Stock Analysis on TRNS

Transcat Stock Performance

NASDAQ TRNS opened at $81.73 on Thursday. The company's 50 day simple moving average is $82.57 and its two-hundred day simple moving average is $85.97. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.29 and a quick ratio of 1.87. Transcat has a 1 year low of $67.56 and a 1 year high of $147.12. The stock has a market capitalization of $761.72 million, a PE ratio of 52.39 and a beta of 0.75.

Transcat (NASDAQ:TRNS - Get Free Report) last issued its earnings results on Monday, May 19th. The scientific and technical instruments company reported $0.64 EPS for the quarter, missing the consensus estimate of $0.66 by ($0.02). The company had revenue of $77.13 million during the quarter, compared to the consensus estimate of $76.40 million. Transcat had a return on equity of 6.47% and a net margin of 5.21%. The business's quarterly revenue was up 8.8% on a year-over-year basis.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in TRNS. Jones Financial Companies Lllp raised its position in Transcat by 686.7% during the fourth quarter. Jones Financial Companies Lllp now owns 354 shares of the scientific and technical instruments company's stock valued at $37,000 after purchasing an additional 309 shares in the last quarter. Quantbot Technologies LP purchased a new position in shares of Transcat during the 1st quarter valued at about $76,000. State of Wyoming bought a new stake in Transcat in the 1st quarter worth approximately $95,000. Aquatic Capital Management LLC lifted its position in Transcat by 1,052.0% in the 4th quarter. Aquatic Capital Management LLC now owns 1,152 shares of the scientific and technical instruments company's stock worth $122,000 after buying an additional 1,052 shares during the last quarter. Finally, GAMMA Investing LLC boosted its stake in Transcat by 10,137.5% in the first quarter. GAMMA Investing LLC now owns 1,638 shares of the scientific and technical instruments company's stock worth $122,000 after buying an additional 1,622 shares in the last quarter. 98.34% of the stock is currently owned by hedge funds and other institutional investors.

Transcat Company Profile

(Get Free Report)

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

Featured Articles

Earnings History and Estimates for Transcat (NASDAQ:TRNS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Transcat Right Now?

Before you consider Transcat, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Transcat wasn't on the list.

While Transcat currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Next Palantir? AI-Defense Stock Set for Explosive Growth
2 Chip Stocks Are Soaring—But One Could Break Out This Summer
Congress Bought This Stock at the Bottom—Will You Miss It?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines